Content on this page requires a newer version of Adobe Flash Player.
RECENT NEWS
February 29, 2012
-
EyeGate Pharma Initiates Phase I Study of EGP-437 in Patients with Non-necrotizing Anterior Scleritis
January 5, 2012
-
EyeGate Pharma initiates Phase III Study of EGP-437 in Patients with Anterior Uveitis
Content on this page requires a newer version of Adobe Flash Player.
Caution: New drug limited by Federal law
to investigational use only. Not for sale.
